Theranostic Applications of Lutetium-177 in Radionuclide Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|9|1|94-101

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.9, Iss.1, 2015-11, pp. : 94-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lutetium-177 Labeled Bombesin Peptides for Radionuclide Therapy

By  

Current Radiopharmaceuticals, Vol. 9, Iss. 1, 2015-11 ,pp. : 33-43

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Lutetium-177 Labeled Therapeutics: Emerging Importance for Cancer Treatment and Therapy of Chronic Disease)

By  

Current Radiopharmaceuticals, Vol. 8, Iss. 2, 2015-08 ,pp. : 77-77

Bentham Science Publishers

Access to resources Recommend Favorite

Radionuclide therapy

By Bomanji Jamshed B  

Clinical Medicine, Vol. 6, Iss. 3, 2006-05 ,pp. : 249-253

Royal College Of Physicians

Access to resources Recommend Favorite

Evolving Important Role of Lutetium-177 for Therapeutic Nuclear Medicine

By  

Current Radiopharmaceuticals, Vol. 8, Iss. 2, 2015-08 ,pp. : 78-85

Bentham Science Publishers

Access to resources Recommend Favorite

Lutetium-177 Labeled Peptides: The European Institute of Oncology Experience

By  

Current Radiopharmaceuticals, Vol. 9, Iss. 1, 2015-11 ,pp. : 19-32

Bentham Science Publishers

Access to resources Recommend Favorite